Description:

cdmo refers to Catalent Inc., a prominent Contract Development and Manufacturing Organization listed on the New York Stock Exchange. Catalent specializes in providing advanced delivery technologies and development solutions for drugs, biologics, gene therapies, and consumer health products. The company operates globally, offering a wide range of services from early-stage drug development through clinical and commercial manufacturing. With its extensive expertise and innovative capabilities, Catalent supports pharmaceutical companies in accelerating their product launches and improving patient outcomes.

Data:

Yields: